PL376302A1 - Nowe zastosowanie siarczanu dekstranu - Google Patents

Nowe zastosowanie siarczanu dekstranu

Info

Publication number
PL376302A1
PL376302A1 PL03376302A PL37630203A PL376302A1 PL 376302 A1 PL376302 A1 PL 376302A1 PL 03376302 A PL03376302 A PL 03376302A PL 37630203 A PL37630203 A PL 37630203A PL 376302 A1 PL376302 A1 PL 376302A1
Authority
PL
Poland
Prior art keywords
dextran sulfate
new use
human patient
cell transplant
therapeutic
Prior art date
Application number
PL03376302A
Other languages
English (en)
Other versions
PL216067B1 (pl
Inventor
Bo Nilsson
Olle Korsgren
Original Assignee
Prophymed Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prophymed Ab filed Critical Prophymed Ab
Publication of PL376302A1 publication Critical patent/PL376302A1/pl
Publication of PL216067B1 publication Critical patent/PL216067B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
PL376302A 2002-11-28 2003-11-26 Zastosowanie siarczanu dekstranu PL216067B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0203526A SE525461C3 (sv) 2002-11-28 2002-11-28 Ny användning av dextransulfat

Publications (2)

Publication Number Publication Date
PL376302A1 true PL376302A1 (pl) 2005-12-27
PL216067B1 PL216067B1 (pl) 2014-02-28

Family

ID=20289705

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376302A PL216067B1 (pl) 2002-11-28 2003-11-26 Zastosowanie siarczanu dekstranu

Country Status (25)

Country Link
US (5) US8629123B2 (pl)
EP (1) EP1567171B1 (pl)
JP (2) JP4315908B2 (pl)
KR (1) KR100828807B1 (pl)
CN (1) CN1296051C (pl)
AT (1) ATE359798T1 (pl)
AU (1) AU2003302378B2 (pl)
BR (1) BRPI0316666B8 (pl)
CA (1) CA2507595C (pl)
CY (1) CY1106739T1 (pl)
DE (1) DE60313356T2 (pl)
DK (1) DK1567171T3 (pl)
EA (1) EA010409B1 (pl)
ES (1) ES2285270T3 (pl)
HR (1) HRP20050439B1 (pl)
IL (1) IL168626A (pl)
IS (1) IS2405B (pl)
NO (1) NO326946B1 (pl)
NZ (1) NZ540744A (pl)
PL (1) PL216067B1 (pl)
PT (1) PT1567171E (pl)
SE (1) SE525461C3 (pl)
SI (1) SI1567171T1 (pl)
WO (1) WO2004047848A1 (pl)
ZA (1) ZA200504111B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2086553A4 (en) * 2006-10-20 2010-12-29 Univ Australian SUPPRESSION OF REMOVAL OF EXTRACELLULAR MATRIX
US20110008343A1 (en) * 2007-06-08 2011-01-13 Lambris John D Method Of Reducing Tissue Loss In Pancreatic Islet Cell Transplantation
US20130143840A1 (en) * 2010-03-12 2013-06-06 Christopher Richard Parish Heparan sulfate replacement therapy
ES2732819T3 (es) * 2010-07-16 2019-11-26 Tx Medic Ab Terapia celular
CN102973592A (zh) * 2012-11-26 2013-03-20 合肥博太医药生物技术发展有限公司 硫酸葡聚糖在制备治疗糖尿病药物中的应用
SE537742C2 (sv) 2013-05-13 2015-10-13 Tx Medic Ab Dextransulfat för cellmobilisering
GB201408233D0 (en) 2014-05-09 2014-06-25 Austrianova Singapore Pte Ltd Use of polyanionic composition
WO2015190989A1 (en) * 2014-06-12 2015-12-17 Tx Medic Ab The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject
BR112016029008B1 (pt) 2014-06-12 2023-05-02 Tx Medic Ab Uso de sulfato de dextrana com peso molecular médio abaixo de 10000 da para induzir a angiogênese em um sujeito
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
SE539575C2 (en) * 2015-07-30 2017-10-17 Tx Medic Ab Dextran sulfate for use in treating, inhibiting or preventing cardiac fibrosis
WO2019050460A1 (en) * 2017-09-08 2019-03-14 Tx Medic Ab NEW USE OF DEXTRANE SULFATE
JP7758356B2 (ja) * 2020-04-15 2025-10-22 ティーエックス メディック エービー 敗血症および高サイトカイン血症の治療薬
SE544447C2 (en) * 2020-09-29 2022-05-31 Tx Medic Ab Treatment of fatty liver diseases
SE544768C2 (en) * 2021-03-24 2022-11-08 Tx Medic Ab Combination for treatment of thromboinflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
TW318142B (pl) 1991-06-03 1997-10-21 Mitsubishi Chemicals Co Ltd
US5464815A (en) 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
CN1178070A (zh) * 1996-09-27 1998-04-08 刘春江 组织脏器移植用保存溶液·手术等时组织脏器保护溶液
CN1057192C (zh) * 1997-09-10 2000-10-11 上海长征医院 一种配制多器官保存液的方法

Also Published As

Publication number Publication date
HRP20050439A2 (en) 2005-12-31
AU2003302378A1 (en) 2004-06-18
SE525461C3 (sv) 2005-03-23
CA2507595C (en) 2011-11-08
CA2507595A1 (en) 2004-06-10
SE0203526L (sv) 2004-05-29
EP1567171B1 (en) 2007-04-18
US10307440B2 (en) 2019-06-04
ES2285270T3 (es) 2007-11-16
IL168626A (en) 2011-06-30
SI1567171T1 (sl) 2007-08-31
US20140094435A1 (en) 2014-04-03
US20100113389A1 (en) 2010-05-06
DK1567171T3 (da) 2007-07-16
US8901104B2 (en) 2014-12-02
BR0316666A (pt) 2005-10-11
DE60313356D1 (de) 2007-05-31
SE0203526D0 (sv) 2002-11-28
US8629123B2 (en) 2014-01-14
JP2006509057A (ja) 2006-03-16
SE525461C2 (sv) 2005-02-22
JP4315908B2 (ja) 2009-08-19
HK1087042A1 (en) 2006-10-06
DE60313356T2 (de) 2007-08-16
JP2009167201A (ja) 2009-07-30
KR100828807B1 (ko) 2008-05-09
CN1296051C (zh) 2007-01-24
IS7908A (is) 2005-06-23
ATE359798T1 (de) 2007-05-15
BRPI0316666B8 (pt) 2021-05-25
WO2004047848A1 (en) 2004-06-10
NO326946B1 (no) 2009-03-16
BRPI0316666B1 (pt) 2018-09-25
PL216067B1 (pl) 2014-02-28
KR20050089803A (ko) 2005-09-08
CY1106739T1 (el) 2012-05-23
US20060111319A1 (en) 2006-05-25
US8906884B2 (en) 2014-12-09
EA010409B1 (ru) 2008-08-29
NZ540744A (en) 2007-02-23
AU2003302378B2 (en) 2008-02-21
US20140093484A1 (en) 2014-04-03
JP4972113B2 (ja) 2012-07-11
US20160136331A1 (en) 2016-05-19
NO20052505L (no) 2005-06-20
ZA200504111B (en) 2006-07-26
US9364499B2 (en) 2016-06-14
PT1567171E (pt) 2007-07-09
EP1567171A1 (en) 2005-08-31
EA200500757A1 (ru) 2005-12-29
HRP20050439B1 (hr) 2007-11-30
CN1717240A (zh) 2006-01-04
IS2405B (is) 2008-09-15

Similar Documents

Publication Publication Date Title
PL376302A1 (pl) Nowe zastosowanie siarczanu dekstranu
EP2277992A3 (en) Progenitor cells from Wharton's jelly of human umbilical cord
AU7432796A (en) Retrievable bioartificial implants
AU5647996A (en) Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives
AU3155700A (en) New biomaterials
NZ517772A (en) Cytotoxic agents comprising taxanes and their therapeutic use
AU2003245282A1 (en) Stent coatings with sustained drug release rate
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
DE60327843D1 (de) Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid
AU2002239830A1 (en) Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof
SI1546088T1 (sl) Spojine za uporabo v zdravljenju avtoimunskih bolezni, imunoalergijskih bolezni in zavrnitve transpalantata organa ali tkiva
IT1307829B1 (it) Protesi dentale con mezzi per il rilascio di farmaci o fattorispecifici atti ad impedire l'insorgenza di infezioni e/o promuovere
NZ507203A (en) Use of dexmedetomidine for ICU sedation
EP2364708A3 (en) Pharmaceutical composition comprising a ClC-2 channel opener
BR0312365A (pt) Meio de cultura autólogo de células-mães progenitoras autólogas humanas, métodos para a preparação do mesmo e de uma composição de células-mães progenitoras autólogas humanas e para a obtenção de células-mães progenitoras musculares autólogas humanas, emprego de um meio de cultura autólogo de células-mães progenitoras autólogas humanas, procedimento para a obtenção de células-mães progenitoras musculares autólogas humanas e procedimento terapêutico de cardiomioplastia celular autóloga, composição enriquecida com células-mães progenitoras musculares autólogas humanas e composição farmacêutica
AU2002952492A0 (en) Chaperonin 10 immunosuppression
HUS1900041I1 (hu) Treoszulfán alkalmazása betegek csontvelõ- és vér õssejt-transzplantáció elõtti kondicionálására
MXPA02005069A (es) Agentes de enlace especificos para t3 y metodos para su uso.
NZ533483A (en) Combinations of viscoelastics for use during surgery
IL131478A0 (en) Methods for treatment of scar tissue
GEP20043231B (en) Resorcinol Composition
WO2003072019A3 (en) Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog
PL361732A1 (pl) Zastosowanie materiału biologicznego zawierającego trójwymiarowy szkielet z pochodnych kwasu hialuronowego do wytwarzania implantów w artroskopii i zestaw do przyrządów do wszczepiania takiego materiału biologicznego na drodze artroskopii
RU99111148A (ru) Глазные капли
EP1347754A4 (en) COMPOSITIONS FOR PREVENTION OF ADHESION